scholarly journals Quality of life and its associations with illness perceptions over a 3‑month follow‑up period in patients with non‑small cell lung cancer: A prospective longitudinal study

2021 ◽  
Vol 3 (6) ◽  
Author(s):  
Ayako Matsuda ◽  
Kunihiko Kobayashi ◽  
Kaoru Kubota ◽  
Yukari Tsubata ◽  
Kenichi Inoue ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Longitudinal Study ◽  
Illness Perceptions ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prospective Longitudinal Study ◽  
Prospective Longitudinal

scholarly journals Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study

2020 ◽  
Vol Volume 11 ◽  
pp. 67-71
Author(s):  
Manja Vollmann ◽  
Ayako Matsuda ◽  
Judith R Kroep ◽  
Kunihiko Kobayashi ◽  
Kaoru Kubota ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Pilot Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Illness Perceptions ◽  
Small Cell ◽  
Small Cell Lung

A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931

1997 ◽  
Vol 18 (4) ◽  
pp. 286-300 ◽  
Author(s):  
James E. Herndon ◽  
Stewart Fleishman ◽  
Michael P. Kosty ◽  
Mark R. Green
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Longitudinal Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Group B ◽  
Leukemia Group

scholarly journals Changes in self-rated health and quality of life among Syrian refugees migrating to Norway: a prospective longitudinal study

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Jasmin Haj-Younes ◽  
Elisabeth Marie Strømme ◽  
Jannicke Igland ◽  
Bernadette Kumar ◽  
Eirik Abildsnes ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Longitudinal Study ◽  
Syrian Refugees ◽  
Prospective Longitudinal Study ◽  
Mean Values ◽  
Self Rated Health ◽  
Prospective Longitudinal ◽  
Over Time

Abstract Background Forced migrants can be exposed to various stressors that can impact their health and wellbeing. How the different stages in the migration process impacts health is however poorly explored. The aim of this study was to examine changes in self-rated health (SRH) and quality of life (QoL) among a cohort of adult Syrian refugees before and after resettlement in Norway. Method We used a prospective longitudinal study design with two assessment points to examine changes in health among adult Syrian resettlement refugees in Lebanon accepted for resettlement in Norway. We gathered baseline data in 2017/2018 in Lebanon and subsequently at follow-up one year after arrival. The main outcomes were good SRH measured by a single validated item and QoL measured by WHOQOL-BREF. We used generalized estimating equations to investigate changes in outcomes over time and incorporated interaction terms in the models to evaluate effect modifications. Results In total, 353 subjects participated in the study. The percentage of participants reporting good SRH showed a non-significant increase from 58 to 63% RR, 95%CI: 1.1 (1.0, 1.2) from baseline to follow-up while mean values of all four QoL domains increased significantly from baseline to follow-up; the physical domain from 13.7 to 15.7 B, 95%CI: 1.9 (1.6, 2.3), the psychological domain from 12.8 to 14.5 B, 95%CI: 1.7 (1.3, 2.0), social relationships from 13.7 to 15.3 B, 95%CI: 1.6 (1.2, 2.0) and the environmental domain from 9.0 to 14.0 5.1 B, 95%CI: (4.7, 5.4). Positive effect modifiers for improvement in SRH and QoL over time include male gender, younger age, low level of social support and illegal status in transit country. Conclusion Our results show that good SRH remain stable while all four QoL domains improve, most pronounced in the environment domain. Understanding the dynamics of migration and health is a fundamental step in reaching health equity.

LuCaS (Lung Cancer Surveillance) study: Surveillance models for advanced lung cancer patients.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e20546-e20546
Author(s):  
Sarah Anne Fraser
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Health Care ◽  
Cancer Patients ◽  
Small Cell ◽  
Advanced Lung Cancer ◽  
Small Cell Lung ◽  
Lung Cancer Patients

e20546 I hope to present the trial protocol as a poster at ASCO with co design work commencing 2017. Background: Lung cancer is the leading cause of cancer death in NZ.1 85% of registrations annually are stage four at diagnosis, presenting a significant burden on resources. Despite novel therapies, survival is poor and quality of life is a key consideration in patient management .2,3 Currently the aim of surveillance is to detect for disease progression and follows a three monthly pattern. There is little literature around benefits of surveillance on survival, and quality of life in these patients. 4-6 Alternative approaches to surveillance should be evaluated to ensure safe, convenient, economical care. Lung cancer outcomes for Maori patients sit significantly lower than those for New Zealand Europeans. Maori patients are twice as likely to present with locally advanced disease and four times less likely to receive curative treatment (multivariate analysis). There are significant barriers for Maori patients to attending health care including time off work, health literacy, costs, child care, language barriers, and transport. 19 Ministry of Health data describes poor outcomes for Maori lung cancer patients with rate of death sitting at 3.4 times that of non-Maori. Co-Primary End Points To determine if there is a reduction in health services utilisation (ED visits, hospital visits, unplanned clinic visits, GP visits, and Nurse Specialist contact) with the end point identified at progression, lost to follow up, or death. To compare the impact of a novel virtual surveillance model (VSM) versus usual follow-up care on patient anxiety measured using the HADS-A tool. Methods: LuCaS is a Randomised Controlled trial in patients with advanced lung cancer randomised to virtual model or standard care. Results: recruitment begins this year. Conclusions: Hypothesis:A virtual follow up model for advanced stage non-small cell lung cancer patients, extensive stage small cell lung cancer patients, and mesothelioma patients will reduce health care utilisation and patient experienced anxiety defined by reduction in Hospital Anxiety and Depression Scale (HADS-A) score, while maintaining effectiveness detecting recurrence and survival.

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years’-follow-up results from a randomised phase III trial

Lung Cancer ◽  
2006 ◽  
Vol 53 (1) ◽  
pp. 67-75 ◽  
Author(s):  
Martin Reck ◽  
Joachim von Pawel ◽  
Hans-Nicholas Macha ◽  
Eckhard Kaukel ◽  
Karl-Matthias Deppermann ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Trial

Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer

Lung Cancer ◽  
2011 ◽  
Vol 72 (3) ◽  
pp. 384-390 ◽  
Author(s):  
Ad A. Kaptein ◽  
Kazue Yamaoka ◽  
Lucia Snoei ◽  
Kunihiko Kobayashi ◽  
Yuka Uchida ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Illness Perceptions ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document